AN
Amir Nashat
Venture CapitalActiveManaging Partner at Polaris Partners
79
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Amir Nashat.
Investment Thesis & Strategy
Polaris Partners invests in various stages across biotech, consumer internet, healthcare, energytech, and health & hospital services, seeking innovative companies with high growth potential.
Portfolio Companies
Selected investments from their portfolio of 79 companies
J
Jnana
Other · , 0
K
KenSci
Healthcare · Series A, 0
E
EGenesis
Biotech · Series B, 0
A
Automotive Titling Company
Other · Seed, 0
F
Foresight Mental Health
Healthcare · Seed, 0
Q
Quentis Therapeutics
Biotech · Series A, 0
N
Neogene Therapeutics
Biotech · Series A, 0
K
Kronos Bio
Other · , 0
F
FidoCure
Other · , 0
S
SQZ Biotech
Other · , 0
T
Twistlock
Other · , 0
G
Gossamer Bio
Other · , 0
Frequently Asked Questions
Amir Nashat focuses on Series A, Series B, Series C+ stage investments.
Related Investors
General Catalyst
Cambridge, United States · 737 deals
Atlas Venture
Cambridge, United States · 514 deals
F-Prime Capital
Cambridge, United States · 228 deals
MPM Capital
Cambridge, United States · 223 deals
Accomplice
Cambridge, United States · 222 deals
Flagship Pioneering
Cambridge, United States · 213 deals